Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ARQT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 12.3M | $290.4M | +3.0% | 9.855% | 7.88% |
| 2 | Frazier Life Sciences Management, L.P. | 9.9M | $232.6M | 0.0% | 7.894% | 5.99% |
| 3 | BlackRock, Inc. | 9.2M | $216.8M | +1.1% | 7.355% | 0.00% |
| 4 | Rubric Capital Management LP | 8.3M | $194.9M | 0.0% | 6.613% | 2.39% |
| 5 | STATE STREET CORP | 6.3M | $148.3M | +14.7% | 5.034% | 0.01% |
| 6 | Polar Capital Holdings Plc | 5.7M | $133.5M | +2.0% | 4.530% | 0.47% |
| 7 | JENNISON ASSOCIATES LLC | 5.0M | $117.3M | -26.3% | 3.982% | 0.08% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 4.9M | $114.8M | — | 3.895% | 0.00% |
| 9 | GILDER GAGNON HOWE & CO LLC | 4.3M | $101.4M | -3.4% | 3.441% | 1.22% |
| 10 | MORGAN STANLEY | 4.2M | $99.4M | -2.8% | 3.373% | 0.01% |
| 11 | UBS Group AG | 3.3M | $78.4M | +2.6% | 2.662% | 0.01% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 3.0M | $71.8M | +10.6% | 2.435% | 0.00% |
| 13 | D. E. Shaw & Co., Inc. | 2.5M | $58.8M | -7.0% | 1.996% | 0.06% |
| 14 | MARSHALL WACE, LLP | 2.4M | $57.3M | +435.4% | 1.944% | 0.06% |
| 15 | FRANKLIN RESOURCES INC | 2.3M | $54.1M | +20.9% | 1.837% | 0.01% |
| 16 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.2M | $52.4M | -13.1% | 1.780% | 0.39% |
| 17 | BANK OF AMERICA CORP /DE/ | 2.2M | $52.3M | +32.7% | 1.776% | 0.00% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $46.1M | — | 1.563% | 0.00% |
| 19 | JANUS HENDERSON GROUP PLC | 1.9M | $43.7M | +1.3% | 1.483% | 0.02% |
| 20 | GOLDMAN SACHS GROUP INC | 1.6M | $37.8M | +1.7% | 1.282% | 0.00% |
| 21 | AMERICAN CENTURY COMPANIES INC | 1.5M | $34.5M | -0.3% | 1.170% | 0.02% |
| 22 | OBERWEIS ASSET MANAGEMENT INC/ | 1.4M | $32.2M | +69.0% | 1.092% | 0.95% |
| 23 | Pivotal bioVenture Partners Investment Advisor LLC | 1.4M | $31.9M | -0.8% | 1.084% | 11.42% |
| 24 | Ensign Peak Advisors, Inc | 1.2M | $29.3M | -34.6% | 0.995% | 0.05% |
| 25 | Squarepoint Ops LLC | 1.1M | $26.0M | +142.1% | 0.882% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ARQT — a direct measure of their conviction.
Filings activity in ARQT during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 262 | 4.4% | 100.27% | 19.71 pp | $3.06B | 16% |
| Q4 2025 | 274 | +20% | 119.98% | +43.59 pp | $3.66B | +57% |
| Q3 2025 | 229 | +3.2% | 76.39% | +19.28 pp | $2.33B | +34% |
| Q2 2025 | 222 | 4.3% | 57.11% | 5.19 pp | $1.74B | 8.3% |
| Q1 2025 | 232 | +13% | 62.30% | +0.46 pp | $1.90B | +0.7% |
| Q4 2024 | 205 | +12% | 61.84% | +24.69 pp | $1.89B | +66% |
| Q3 2024 | 183 | +1.7% | 37.15% | +0.66 pp | $1.13B | +1.8% |
| Q2 2024 | 180 | — | 36.49% | — | $1.11B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ARQT stock.
Based on Q1 2026 13F filings, institutional ownership of Arcutis Biotherapeutics, Inc. stands at 100.3%, held across 262 reporting institutions.
SUVRETTA CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of ARQT, with approximately 12,327,000 shares worth $0.29B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of ARQT.
Our composite Smart Money Score for ARQT is 21 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
42 institutions opened new positions in ARQT during Q1 2026, while 54 fully exited. 49 added to existing positions and 169 trimmed.
ARQT institutional ownership fell by 19.71 percentage points quarter-over-quarter, with a net change of -12 holders.
The top 10 institutions account for 53.9% of all reported 13F value in ARQT, and the top 25 account for 77.1%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Arcutis Biotherapeutics, Inc. (ARQT) Institutional Ownership